Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia

Title
Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia
Authors
Keywords
Trigeminal neuralgia, Double-blind randomized withdrawal study, Sodium channel blocker, Neuropathic pain
Journal
Trials
Volume 14, Issue 1, Pages 402
Publisher
Springer Nature
Online
2013-11-23
DOI
10.1186/1745-6215-14-402

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now